MWA
AVNS

Medallion Wealth Advisors’s Avanos Medical AVNS Stock Holding History

Medallion Wealth Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$299 Sell
12
-124
-91% -$2.9K ﹤0.01% 1050
2026
Q1 		$1.91K Hold
136
– – ﹤0.01% 1005
2025
Q4 		$1.53K Hold
136
– – ﹤0.01% 1019
2025
Q3 		$1.57K Hold
136
– – ﹤0.01% 1002
2025
Q2 		$1.67K Hold
136
– – ﹤0.01% 975
2025
Q1 		$1.95K Buy
136
+12
+10% +$187 ﹤0.01% 925
2024
Q4 		$1.78K Buy
+124
New +$2.45K ﹤0.01% 876

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Medallion Wealth Advisors's AVNS Position: Q2 2026 in Review

Medallion Wealth Advisors reduced its Avanos Medical (AVNS) stake by 91% in Q2 2026, selling an estimated $2.9K and leaving 12 shares worth $299. The position accounts for ﹤0.01% of the portfolio, ranked #1050.

Medallion Wealth Advisors first reported a position in AVNS in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.95K in Q1 2025. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Medallion Wealth Advisors held 12 shares of Avanos Medical worth $299 as of Q2 2026.
  • Medallion Wealth Advisors sold 124 Avanos Medical shares in Q2 2026, an estimated $2.9K.
  • Avanos Medical made up ﹤0.01% of Medallion Wealth Advisors's portfolio in Q2 2026, its #1050 holding.
  • Medallion Wealth Advisors first reported a position in Avanos Medical in Q4 2024 and has held it in 7 quarters since.
  • Medallion Wealth Advisors's Avanos Medical position peaked at $1.95K in Q1 2025.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Medallion Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.